Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).
Emin AbdullayevOmer KilicGurkan BozanEylem KiralMerve Iseri NepesovEner Çağrı DinleyiciPublished in: Human vaccines & immunotherapeutics (2020)
Our clinical work with 5-days IgM-enriched intravenous immunoglobulin may reveal a survival benefit of this treatment for children with septic shock.